Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
1154 results
100480 - The Association Between Selective IgA Deficiency and Bronchial Asthma in Children Aged 4–18 Years: A Systematic Review
100509 - The cause of perioperative hypersensitivity in adults and consequences of subsequent anesthesia
100514 - Chronic urticaria and eradication of helicobacter pillory-evaluation of treatment results
100516 - Systemic reaction with dry powder device in patient allergic to milk
100536 - Late onset immunodeficiency in children
100541 - Systematic evaluation of ChatGPT`s performance on 40 dermatological allergology questions with clinical error impact assessment for erroneous AI-guided chatbot-advice
100606 - Cofactor-mediated spice anaphylaxis: a case report
100607 - Eating Under Observation
100629 - Asthma outcomes in young adults completed sublingual immunotherapy in adolescence
100631 - Long-term post treatment benefits of house dust mites sublingual immunotherapy in polysensitized children
D1.103 - Two cases of discrepancy between fractional exhaled nitric oxide and airway eosinophils in asthma
D1.104 - Severe Bronchial Asthma Phenotypes in a Referral Tertiary Center in Saudi Arabia
D1.116 - Severe Airflow Limitation Unmasked by NSAID Hypersensitivity: A Case of Undiagnosed Persistent Asthma with Nasal Polyposis
D1.117 - Combing dual biologics therapy for severe asthma : a series of ten cases
D1.118 - The Use of Long-Acting Muscarinic Antagonist in the Treatment of Asthma: A Latin-American 2 Specialized Asthma Center Experience
D1.119 - Anti-Inflammatory Effects of miRNA-Mediated Extracellular Vesicles Derived from Mesenchymal Stem Cells in a Murine Asthma Model
D1.122 - Hydrogen peroxide in exhaled breath condensate as a marker for monitoring biologic treatment response in severe asthmatic patients
D1.123 - Inhibition of the Interleukin Cytokines using novel Peptide Inhibitors for Allergy and Asthma Treatment
D1.124 - Predictive Factors of Clinical Remission in Severe Eosinophilic Asthma Treated with Benralizumab
D1.125 - Biological therapy in severe asthma: 20 years of experience at the Hospital Universitario de Burgos
Pagination
First page
First
Previous page
Previous
Page
1
Page
2
Page
3
Page
4
Current page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download